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0022-2836 © 2011 Published by ElsevierPolyubiquitination is an essential posttranslational modification that plays
critical roles in cellular signaling. PolyUb (polyubiquitin) chains are formed
by linking the carboxyl-terminus of one Ub (ubiquitin) subunit to either a
lysine residue or the amino-terminus of an adjacent Ub. Linkage through
the amino-terminus results in linear polyubiquitination that has recently
been demonstrated to be a key step in nuclear factor κB activation; however,
tools to study linear chains have been lacking. We therefore engineered a
linear-linkage-specific antibody that is functional in Western blot, immu-
noprecipitation, and immunofluorescence applications. A crystal structure
of the linear-linkage-specific antibody Fab fragment in complex with linear
diubiquitin provides molecular insight into the nature of linear chain
specificity. We use the antibody to demonstrate that linear polyUb is up-
regulated upon tumor necrosis factor α stimulation of cells, consistent with
a critical role in nuclear factor κB signaling. This antibody provides an
essential tool for further investigation of the function of linear chains.© 2011 Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Ubiquitination is a posttranslational modification
where the carboxyl-terminus of Ub (ubiquitin) is
linked through an isopeptide bond to a lysine orress: rk@gene.com.
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Ltd. Open access under CC Boccasionally the amino-terminus of a substrate
protein. This process is catalyzed by an E1 activating
enzyme, an E2 conjugating enzyme, and an E3
ligase.1–3 Monoubiquitination occurs with the
attachment of a single Ub, and polyUb (polyubiquitin)
chains can be built by linking additional Ubs to the
first Ub. PolyUb chains can be joined together in two
ways. In lysine-linked chains, the carboxyl-terminus
of Ub is linked through an isopeptide bond to one of
seven lysines of the adjacent Ub, whereas in linear-
linked chains, it is linked through a canonical peptide
bond to the amino-terminus. Thus, there are eight
possible polyUb linkages that can be formed.
Each polyUb linkage has a distinct structure
and associated function. Crystal structures of five
of the linkages have been solved, demonstrating
that K6, K11, and K48 chains adopt unique
compact conformations whereas K63 and linearY-NC-ND license.
135Engineering of a Polyubiquitin-Specific Antibodyform extended chains.4–8 While these structures
show a static conformation, NMR studies and
comparison of structures determined under dif-
ferent crystallization conditions reveal some var-
iation in conformation. 4,5,7,9–11 The unique
structures adopted by the different linkages result
from the differential placement of the lysine or
amino-terminus involved in the linkage. This
presents different surfaces of Ub for interaction
with distinct subsets of Ub-binding proteins that
confer unique functions on the linkages.12
Initially, linear polyUb was thought to function
only as a source for cellular monoUb (monoubiquitin)
as tandem Ub open reading frames are normally
translated and then cleaved into single subunits.
However, linear Ub chain assembly complex
(LUBAC) was recently identified as a multi-subunit
E3 ligase that can enzymatically synthesize linear
chains.13–16 LUBAC functions in nuclear factor κB
(NFκB) pathway activation by modifying NEMO
(NFκB essential modulator) and RIP1 with linear
chains leading to stabilization of the tumor necrosis
factor (TNF) receptor 1-associated signaling
complex17,18 and prevention of TNFα-induced
apoptosis and associated inflammation.13,14,16
Until recently, functions associated with the
different linkages have been elucidated mainly
through the use of Ub lysine mutants and mass
spectrometry. While both of these methods are
important for the study of ubiquitination, they each
have their limitations. Lysine mutants generally
require the use of in vitro assays or over-expression
of the mutants in the presence of endogenous Ub in
cells. In addition, Ub mutants carry the risk of
affecting interaction with other proteins and thus
may not fully recapitulate normal Ub function.
While mass spectrometry can be used to accurately
identify a linkage andmeasure its abundance, it does
require specialized reagents and instrumentation.
Furthermore, neither of these methods allows direct
visualization of Ub chain subcellular localization. To
address these shortcomings, we have engineered
antibodies that recognize K11-, K48-, and K63-linked
polyUbs and proven them useful in studying these
chains.7,19 In this report, we expand the toolbox for
the study of ubiquitination and describe a linear-
specific antibody that can be used for immunofluo-
rescence (IF), immunoprecipitation (IP), and Western
blot applications.Results
Engineering of a linear-polyUb-specific antibody
To aid the study of linear ubiquitination, we
engineered a linear-linkage-specific antibody. Since
phage display had been successful in generatingother polyUb-linkage-specific antibodies,7,19 we
took a similar approach for linear polyUb. A
bivalent Fab fragment phage display library20 was
panned against a linear diUb (diubiquitin). Naïve
clone 1E3 demonstrated selectivity for linear diUb
over other linkages andmonoUb and was functional
in Western blots (Fig. 1a). To improve its sensitivity,
we performed affinity maturation. Given the highly
similar structures of linear and K63-linked polyUb6
(Fig. S1a), special care was taken to maintain
specificity for linear chains. Therefore, the number
of amino acid changes introduced to improve
affinity was limited by constructing libraries ran-
domizing each position of the complementarity-
determining regions (CDRs) individually with all 20
amino acids but allowing only a single residue
substitution in any given clone. Libraries were
sorted against either linear or K63-linked diUb,
and clones that were isolated only in the linear sort
were selected for further analysis. Single amino acid
changes in CDRs L2 (S52K, clone 1F11), H2 (S56Q,
clone 3F5), or H3 (Y102L, clone Y102L) improved
antibody sensitivity for linear diUb inWestern blots,
with the S56Q H2 mutation making the largest
improvement (Fig. 1a). The single mutants were
then combined to make all possible double mutants
that demonstrated increased sensitivity over their
respective single mutants (Fig. 1a). Finally, the triple
mutant 1F11/3F5/Y102L was the most sensitive for
linear diUb recognition (Fig. 1a). In addition, it
maintained specificity for linear diUb, demonstrating
no recognition of monoUb and K6-, K11-, K27-, K29-,
K33-, K48-, or K63-linked diUb by Western blot
(Fig. 1b and c). Although the antibody was selected
for binding linear diUb, it also recognized longer
linear polyUb chains without cross-reacting to
polyUb chains of other linkages (Fig. S1).
Structural insights into Fab recognition of
linear diUb
To understand the structural basis of 1F11/3F5/
Y102L specificity, we crystallized the Fab fragment
in complex with the linear diUb. The crystal
structure was solved to 2.4 Å resolution (Table 1)
[Protein Data Bank (PDB) ID: 3U30] and shows that
1F11/3F5/Y102L recognizes the linear diUb by
contacting both the proximal and the distal Ubs
(Fig. 2a), where proximal and distal refer to the
distance relative to a hypothetical substrate. The HC
(heavy chain) CDRs are responsible for the majority
of interactions, contacting both Ub subunits and
burying 785 Å2 of the solvent-accessible surface area
(Fig. 2b and c). In contrast, the LC (light chain)
contributes relatively little to the interaction with a
few contacts from CDR L2 and none from L1 and L3.
At the heart of the interaction lies the C-terminal tail
of the distal Ub followed by the linear linkage, which
traverse the Fab paratope making contacts with all
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Fig. 1. Affinity maturation of a linear polyUb-specific antibody and its functionality in Western blots. (a) Threefold
serial dilutions of linear diUb (12–1000 ng/lane=gradient) and 1 μg of K63-linked diUb were immunoblotted with the
parental (1E3), single, double, and triple mutant IgGs. Signal intensity bands were quantified and given in arbitrary
units. (b) Twofold serial dilutions of linear diUb (16–1000 ng/lane=gradient) and 1 μg each of monoUb and K11-,
K48-, and K63-linked diUbs were immunoblotted with the parental clone 1E3, the triple mutant 1F11/3F5/Y102L, or
Coomassie stained. ∗, linear diUb that dimerizes. (c) MonoUb and K6-linked, K11-linked, K27-linked, K29-linked, K33-
linked, K48-linked, K63-linked, and linear diUbs (1 μg/lane) were immunoblotted with 1F11/3F5/Y102L or
Coomassie stained. ∗, linear diUb that multimerizes.
136 Engineering of a Polyubiquitin-Specific Antibodythree HC CDRs. L71 and L73 of the C-terminal tail
bind in an HC hydrophobic pocket, and hydrogen
bonds are made between R74 of the distal Ub andY33 of H1, R74 of the distal Ub and R99 of H3, G75 of
the distal Ub andQ56 of H2, and G76 of the distal Ub
and linear linkage and Q56 of H2 (Figs. 2d and 3a).
Table 1. X-ray data collection and refinement statistics
Data collection
Space group P1
Cell dimensions
a, b, c (Ǻ) 53.32, 59.77, 96.03
α, β, γ (°) 87.09, 76.77, 71.70
Resolution (Ǻ) 50.00–2.43
(2.52–2.43)
Rmerge 8.1 (35.4)
〈I/σI〉 9.9 (2.1)
Completeness (%) 97.2 (96.9)
Redundancy 1.9 (1.8)
Observed reflections 66,661
Unique reflections 39,225
Refinement
Resolution (Ǻ) 2.43
Number of reflections 37,268
Reflections in Rfree set 1957
Fab–diUb complexes in the asymmetric unit 2
Rwork/Rfree (%) 23.0/25.9
Average B-factor (Ų)
Complex 1
First Ub 33.3
Second Ub 35.8
Fab 42.1
Complex 2
First Ub 50.0
Second Ub 46.0
Fab 40.7
Solvent 33.2
Overall B-factor (Ų) 45.5
Wilson B-factor (Ų) 50.9
Number of atoms
Protein 8994
Solvent 194
r.m.s.d.
Bond lengths (Ǻ) 0.003
Bond angles (°) 0.817
Ramachandran plot (%)
Preferred regions 85.9
Additionally allowed regions 13.5
Generously allowed regions 0.2
Disallowed regions 0.4
Values in parentheses are for the highest-resolution shell.
Coordinates have been deposited in the PDB (ID: 3U30).
137Engineering of a Polyubiquitin-Specific AntibodyIn the affinity maturation, three mutations
contributed to the improvement in sensitivity of
the antibody: S52K (L2), S56Q (H2), and Y102L
(H3) (Fig. 1a). S56Q, which made the largest
contribution, allows direct contact to the linearFig. 2. Structural analysis of 1F11/3F5/Y102L Fab fragmen
(distal Ub, dark orange; proximal Ub, light orange) and the 1F
Close-up of Fab CDRs in contact with the surface of linear diU
N- and C-termini of diUb are labeled, and the linear linkage i
representation of linear diUb (white) and the Fab (LC, purple; H
relative to the Fab. Epitope and paratope residues defined as
buried at the interface and/or within 4.5 Å of the other membe
are colored according to the Ub subunit to which they belong
residues are colored according to the Ub subunit they contact (d
yellow). Awhite line indicates the demarcation between LC an
into an HC pocket. The Fab is shown as a surface representatio
Side chains of L71 and L73 are shown as spheres. Residues of
they belong (H1, yellow; H2, red; H3, blue).linkage. The side-chain amide makes two hydro-
gen bonds to the distal Ub: one to the main-chain
carbonyl of G75 and the other to the main-chain
carbonyl of G76 and the linear linkage (Fig. 3a). In
addition to the two hydrogen bonds, Q56 also
makes van der Waals contacts to M1 of the
proximal Ub. S52K, which made the second largest
improvement in sensitivity, surprisingly does not
significantly contribute to the binding surface. K52
in L2 creates a positively charged surface patch
that complements a negative patch on the surface
of the distal Ub from D32; however, the effect is
likely indirect as these residues are approximately
8 Å apart. Y102L made the smallest improvement
in sensitivity. This residue is just outside CDR H3
at the beginning of framework 4 and makes
extensive van der Waals contacts with framework
1 of the HC by intercalating between V2 and L4
(Fig. S2c). The more hydrophobic nature of leucine
may be better suited to this interaction and could
potentially stabilize a conformation of CDR H3
that is favorable to binding.
Comparison of linear diUb bound to the Fab
with that of free linear diUb (PDB ID: 2W9N)6
reveals that the Fab binds the diUb in a bent
conformation (Fig. 3c). The bent conformation
exposes the carboxy-terminal tail of the distal Ub
and the linkage allowing the Fab to make
extensive contacts with these regions. This is
similar to the bent conformation seen for K63-
linked diUb bound to the K63-specific Fab (PDB
IDs: 3DVN and 3DVG).19 Alignment of the distal
Ubs of linear and K63-linked diUbs in their Fab
binding conformations demonstrates that although
the distal Ubs could adopt the same conformation,
the orientation of the proximal Ubs will differ due
to the unique positions of M1 or K63 of the
linkage (Fig. 3c). While the antibody could make
all contacts to the distal Ub of K63-linked diUb,
the proximal contacts would likely be disrupted
due to the rotation of the proximal Ub resulting
from the position of K63 versus M1. CDR H2
makes three hydrogen bonds to the proximal Ub:
two to the side chain of Q62 and one to the main-
chain amide of K63 itself (Fig. 3b). H2 also forms
extensive van der Waals interactions achievedt bound to linear diUb. (a) Complex between linear diUb
11/3F5/Y102L Fab fragment (LC, purple; HC, green). (b)
b (white). CDRs are labeled, and coloring is as in (a). The
s indicated by a red asterisk (∗). (c) An open-book surface
C, green). The diUb is rotated 180° about a horizontal axis
having at least 25% of their solvent-accessible surface area
r of the complex are labeled. Residues of the diUb epitope
(distal, dark orange; proximal, light orange). Fab paratope
istal, dark orange; proximal, light orange; contacts to both,
d HC of the Fab. (d) Binding of L71 and L73 of the distal Ub
n, and the diUb is shown as a cartoon and colored as in (a).
the HC pocket are colored according to the CDR to which
138 Engineering of a Polyubiquitin-Specific Antibodythrough its binding in a proximal Ub pocket
surrounded by the side chains of N60, Q62, and
K63 (Fig. 2c). Thus, specificity is achieved through
the recognition of surfaces of both Ub subunits
that are presented in a particular orientation in
the context of the linear linkage.(a)
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To establish whether 1F11/3F5/Y102L could
immunoprecipitate linear polyUb chains and test
its specificity, we mixed purified polyUb chains ofL71 L73
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Fig. 3. Molecular nature of 1F11/3F5/Y102L Fab fragment recognition of linear diUb. (a) Recognition of the distal Ub
C-terminus (dark orange) involves hydrogen bonds with residues from all three HC CDRs (green). Hydrogen bonds are
indicated by black broken lines. (b) Hydrogen bonds between CDR H2 (green) and the proximal Ub (light orange). The
structure is rotated 90° clockwise about a vertical axis relative to the structure in (a). (c) Comparison of the conformations
of linear diUb bound to the linear-specific Fab (left, PDB ID: 3U30), K63-linked diUb bound to the K63-specific Fab
(middle, PDB ID: 3DVN), and free linear diUb (right, PDB ID: 2W9N). Residues G76 of the distal Ub (dark orange) and
K63 or M1 of the proximal Ub (light orange) are shown as spheres to indicate the linkage. Distal Ubs are aligned, and a
green asterisk (∗) is placed near T9 of each proximal Ub to demonstrate relative orientations.
139Engineering of a Polyubiquitin-Specific Antibodythe linear, K11, K48, and K63 linkages. IPs were done
with 1F11/3F5/Y102L or an isotype control anti-
body and probed with the linear (K11, K48, or K63)
linkage-specific antibodies by Western blot (Fig. 4a).
Previously, we found that, for our other linkage-
specific antibodies, IPs were most specific when
carried out in 4 M urea. While 1F11/3F5/Y102L is
able to immunoprecipitate nearly as much linear
polyUb in 4 M urea as without urea, it also pulls
down a significant amount of K63-linked chains,
likely due to their structural similarity. Since the anti-
K63 antibody previously described19 was not tested
for cross-reactivity to linear chains, IPs were also
performedwith this antibody. Interestingly, the anti-
K63 antibody did not pull down linear chains in 4 M
urea, suggesting that it recognizes a conformation of
polyUb not easily achieved by the linear linkage
(data not shown). Increasing concentrations of urea
decreased the amount of K63-linked chains pulled
down by 1F11/3F5/Y102L without significantly
affecting the efficiency of linear chain recovery(Fig. 4a). Surprisingly, it was able to immunopre-
cipitate linear chains in concentrations as high as
7 M urea. Under these conditions, no K11-, K48-, or
K63-linked chains were detected by Western blot.
To confirm this specificity, we analyzed IPs by mass
spectrometry absolute quantification (AQUA) (Fig.
4b). Of the total linkages present in the input in the
gel region analyzed, 7% were linear, 2% were K11,
58% were K48, and 32% were K63. The unequal
linkage representation is due in part to variation in
migration of different linkages and unequal
amounts of each chain length present in the polyUb
mixtures used. IP without urea only slightly
enriched linear chains (12% of total linkages pulled
down were linear) with a significant amount of K48
(25%) and K63 (62%) linkages also being pulled
down. The specificity of the antibody improved as
the concentration of urea was raised such that, in
7 M urea, 99% of the linkages pulled down were
linear. Thus, both AQUA and Western blots
confirm that 1F11/3F5/Y102L is highly specific
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Fig. 4. Characterization of 1F11/3F5/Y102L specificity in IPs. (a) IPs from a mixture of linear-, K11-, K48-, and K63-
linked polyUbs with the 1F11/3F5/Y102L anti-linear (L) or an isotype control (C). IgGwere immunoblotted with linkage-
specific IgGs. Pure linkage chains were run as controls (input). Region analyzed by mass spectrometry AQUA in (b) is
highlighted by red lines. ∗, IgG HC. (b) Linkage composition of the input and anti-linear IPs in (a) as determined by
AQUA. The fold enrichment for the linear and K63 linkages is indicated. (c) Over-expression of Hoil-1L and Hoip in
HEK293T cells increases linear chains detected by Western blot with 1F11/3F5/Y102L.
140 Engineering of a Polyubiquitin-Specific Antibodyfor the linear linkage when IPs are performed in
7 M urea.
To determine whether the antibody could
recognize endogenous polyUb, we analyzed
HEK293T cell lysates by Western blot. Lysates
from cells transfected with an empty vector show
a faint high-molecular-weight smear (Figs. 4c and
5a); however, no linear chains could be identified
by AQUA (Table S1). This suggests possible weak
cross-reactivity to K63 chains by Western blot in
the absence of linear chains and in the presence of
an abundance of K63 chains (N5000-fold more).
When two LUBAC components, Hoil-1L and
Hoip, previously shown to enzymatically synthe-
size linear polyUb15 were over-expressed, the
high-molecular-weight smear recognized by
1F11/3F5/Y102L was greatly enhanced (Fig. 4c),
supporting its recognition of linear chains. To
determine whether 1F11/3F5/Y102L could pull
down linear chains from cells, we performed IPs
on the lysates. When Hoil-1L and Hoip were over-
expressed, 1F11/3F5/Y102L significantly enrichedfor linear polyUb as detected by Western blot
and AQUA (Fig. 5a and b). Whereas 21% of the
total linkages present in the lysates over-expressing
Hoil-1L and Hoip were linear, they accounted for
75% of the total linkages present in the IP
demonstrating that the antibody enriches for linear
chains. The presence of smaller amounts of other
linkages in the IPs is likely due to mixed linkage
chains, substrate proteins modified with homotypic
chains of different linkages, and/or protein com-
plexes resistant to dissociation containing different
polyUb linkages, as IPs were done in 7 M urea.
Indeed, mixed linkage chains and/or substrates
modified with multiple linkages have previously
been suggested.7,19,21–24
To determine whether the antibody could be
used for IF, we stained HeLa cells with
1F11/3F5/Y102L (Fig. 5c). Mock transfected cells
did not show any staining, consistent with little to
no linear polyUb seen by IP and Western blot
above. Over-expression of Hoil-1L and Hoip led
to detection of linear polyUb by 1F11/3F5/Y102L
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Fig. 5. Recognition of endogenous linear polyUb by 1F11/3F5/Y102L. (a) IP of linear chains from HEK293T cells over-
expressing Hoil-1L and Hoip. The region analyzed by mass spectrometry AQUA in (b) is highlighted by red lines. ∗, IgG
HC. (b) Linkage composition of the input and anti-linear IPs in (a) as determined by AQUA. (c) IF with the anti-linear
antibody detects linear chains in HeLa cells over-expressing Hoil-1L and Hoip. Linear polyUb staining is shown in green,
and 4′,6-diamidino-2-phenylindole staining is shown in blue. The specific signal can be eliminated by the addition of
purified linear polyUb (Ub5). (d) Cell lysates and IPs from HeLa S3 cells treated with TNFα for the indicated times were
probed with 1F11/3F5/Y102L. Cell lysates were probed for IκBα to demonstrate NFκB pathway activation and β-tubulin
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141Engineering of a Polyubiquitin-Specific Antibodyand demonstrated a cytoplasmic, punctate stain-
ing pattern for the linear chains, which could be
competed with recombinant linear polyUb. Thus,
the linear-specific antibody is functional in West-
ern blot, IP, and IF applications.
Since linear polyUb has been shown to be involved
in NFκB signaling, we used the antibody to
investigate the time-dependent synthesis of these
chains inHeLa cells in response to TNFα stimulation.
In the absence of TNFα, no linear polyUb chains
could be detected (Fig. 5d). However, after only
5 min of stimulation, linear chains were up-
regulated and further increased with 20 min ofstimulation. This up-regulation correlated with the
degradation of IκBα indicating that linear polyUb
synthesis is initiated during NFκB pathway activa-
tion. This antibody represents a powerful tool for
further investigation of the role of linear chains in
NFκB signaling and other pathways.Discussion
Here, we describe the engineering of a linear
polyUb-specific antibody. While the antibody
makes direct contact to the linear linkage, this
142 Engineering of a Polyubiquitin-Specific Antibodyrepresents only a small portion of the epitope.
Rather, the specificity is derived from recognition of
multiple surrounding surface residues on both Ubs
that are presented in a specific orientation as the
result of the linear linkage. This conformational
epitope results in an antibody that is functional in
IPs and surprisingly also in denaturing Western
blots. This is likely due to the extremely stable
nature of Ub such that the chains either are resistant
to denaturation during SDS-PAGE or are able to
refold on the membrane.
A unique approach was taken for the affinity
maturation of this antibody given the specificity
constraints resulting from the highly similar
structures of linear and K63-linked polyUbs. Single
CDR, single residue scanning libraries were
designed and panned in parallel against both
linear and K63-linked diUbs. Different types of
mutants were selected in the two sorts, and clones
that were isolated only in the sort against linear
diUb were considered for further analysis. This
allowed identification of residues that not only
improved affinity but also maintained specific
binding to linear chains. While single amino acid
changes made incremental improvements in
sensitivity/affinity, combining these mutations
resulted in further improvement while retaining
the specificity for linear polyUb. This represents
a strategy that could be applied to affinity
maturation of other linkage-specific antibodies
or antibodies that must discriminate between
two highly related proteins.
Finally, we use this antibody to demonstrate that
linear chains are up-regulated in HeLa cells in
response to TNFα stimulation, supporting the role
of these chains in NFκB activation. This antibody can
be similarly used to explore potential functions of
linear chains in other signaling pathways in the cell.
Given that the linear polyUb field is in its relative
early stages with much left to understand about this
linkage, this antibody represents a powerful research
tool for the Ub community.†http://www.pymol.orgMaterials and Methods
Plasmids, antibodies, and proteins
Hoil-1L and Hoip open reading frames were cloned
into pBI-CMV1 (Clonetech). The pET15b-linear diUb
expression construct used was previously described
(Dong et al.25). The following antibodies were used:
pan anti-Ub P4D1 (Santa Cruz Biotechnology); Hoil-1L
and Hoip (Abcam); β-tubulin and IκBα (Cell Signaling
Technologies); and K11, K48, and K63 linkage-specific
antibodies (Genentech). The following Ub proteins were
used: monoUb; linear-, K6-, K11-, K27-, K29-, K33-, K48-,
and K63-linked chains (Boston Biochem and Enzo Life
Sciences); and K11-linked chains (Dong et al.25).Phage display
Phage display libraries were generated and sorted as
described previously20 with later rounds containing
soluble monoUb and K11-, K48-, and K63-linked polyUbs
for counter-selection. Affinity maturation libraries were
designed to scan each position of the CDRs individually
using the NNK codon and sorted for binding to either
linear or K63-linked diUb.
Fab–linear diUb complex structure
Linear diUb, 1F11/3F5/Y102L Fab fragment, and the
complex were expressed and purified as previously
described.19,25 Crystals grew over 5 days at 19 °C in
sitting drops from a 2:3 mixture of complex [20 mg/mL
in 25 mM Tris (pH 7.5) and 150 mM NaCl] to well
solution [18% isopropanol, 0.09 M 4-morpholineethane-
sulfonic acid (pH 6.0), 19.8% polyethylene glycol 2000
monomethyl ether, and 10 mM sodium bromide]. For
cryoprotection, well solution was supplemented with an
additional 30% polyethylene glycol 2000 monomethyl
ether. Data were collected at Advanced Light Source
beamline 5.0.2 and processed with HKL2000. The
structure was solved by molecular replacement using
PHASER (CCP4i) using the humanized 4D5 Fab (PDB
ID: 1FVE) and Ub (PDB ID: 1UBQ) as search models,
and the structure was built using Coot and refined with
Phenix. All figures were made with PyMOL†.
Western blots with 1F11/3F5/Y102L
Proteins were separated by SDS-PAGE and transferred
1–2 h at 30 V by wet transfer in 10% methanol to
nitrocellulose. Nonspecific binding sites were blocked
with 5% milk/phosphate-buffered saline (PBS)+0.05%
Tween 20 [PBST (PBS plus Tween 20)]; 1 μg/mL
1F11/3F5/Y102L IgG in 5% milk/PBST was incubated
for 1 h at 25 °C and was detected by a goat anti-human-
HRP F(ab′)2 secondary (Jackson ImmunoResearch). Signal
intensity was quantified using a LiCor Odyssey.
Pure chain IPs
Two micrograms each of linear-, K11-, K48-, and K63-
linked polyUbs were mixed and diluted with IP buffer
[20 mM Tris (pH 7.5), 135 mM NaCl, 1% Triton X-100,
10% glycerol, 1 mM ethylenediaminetetraacetic acid
(EDTA), and 1.5 mM MgCl2] containing 0, 4, 5, 6, or
7 M urea. Samples were precleared with Protein A
Dynabeads (Invitrogen), and IPs were done with
1F11/3F5/Y102L or an isotype control IgG at 25 °C.
IgGs were captured with Protein A Dynabeads, washed
five times with the corresponding IP buffer and twice
with PBS. Proteins were eluted with LDS reducing
sample buffer (Invitrogen) by heating at 70 °C and
were resolved by SDS-PAGE.
143Engineering of a Polyubiquitin-Specific AntibodyHoil-1L and Hoip over-expression
HEK293T cells were transfected with pBI-CMV-Hoil-
1L/Hoip or empty vector using Lipofectamine 2000
(Invitrogen) according to the manufacturer's protocol.
Cells were lysed 48 h post-transfection in 8M urea, 50mM
Tris (pH 7.5), 25 mM NaCl, 1× HALT protease and
phosphatase inhibitors (Thermo Scientific), 5 mM EDTA,
and 2 mM N-ethyl maleimide and were sonicated briefly.
Lysates were diluted to 7 M urea with 50 mM Tris (pH 7.5)
and 25 mM NaCl, and IPs were performed as described
above.
Mass spectrometry AQUA
Mass spectrometry was performed as described
previously.23,26
IF microscopy
HeLa cells (5000 cells/100 μL/well) were seeded in a
clear bottom, black wall 96-well plate and transfected 24 h
later with pBI-CMV-Hoil-1L/Hoip as described above.
Cells were rinsed 18 h post-transfection with PBS, fixed
with ice-cold methanol at −20 °C for 10 min, permeabi-
lized with PBS/0.1% Triton X-100 at 25 °C for 5 min, and
then blocked with PBS/0.3% Triton X-100/5% bovine
serum albumin at 25 °C for 1 h. 1F11/3F5/Y102L IgG
(1 μg/mL) was incubated with or without linear chains
(5 μg/mL Ub5) at 25 °C for 1 h and then used to label cells
at 25 °C for 1 h. After six washes (10 min each) with
PBS/0.05% Triton X-100, cells were stained with
DyLight488-conjugated donkey anti-human antibody
(1:500; Jackson ImmunoResearch) at 25 °C for 1 h. Cells
were washed six times (10 min each) with PBS/0.05%
Triton X-100, stained with Hoechst (1:10,000) at 25 °C for
10 min, and washed with PBS. The plate was covered with
black seals and imaged with an ImageXpressMicro system.
TNFα stimulation
We treated 3 L of HeLa S3 cells (0.55×106 cells/mL)
with 5.8 μM MG132 (Cayman Chemical), and 1 L of cells
was immediately removed. The remaining 2 L was
immediately treated with 100 ng/mL TNFα (Shenando-
ah Biotechnology), and 1 L was removed after 5 and
20 min. Cells from each time point were pelleted,
washed with cold PBS containing 100 ng/mL TNFα,
and repelleted. Cells were lysed in 7 M urea buffer [7 M
urea, 20 mM Tris (pH 7.5), 135 mM NaCl, 1% Triton X-
100, 10% glycerol, 5 mM EDTA, 1.5 mM MgCl2, 10 mM
N-ethyl maleimide, 25 μM MG132, and 1× HALT
protease and phosphatase inhibitors] at 25 °C. Lysates
were sonicated briefly, spun at 10,000g, and precleared
with goat anti-human Fc BioMag beads (Bangs Labora-
tories). Each time point was split into two, and IPs were
done as described above.
Accession numbers
Coordinates and structure factors for the crystal
structure of the Fab bound to linear diUb have beendeposited in the PDB (PDB ID: 3U30). Crystal structures
referenced include Ub (PDB ID: 1UBQ), linear diUb (PDB
ID: 2W9N), K63-linked diUb (PDB ID: 2JF5), K63-specific
Fab bound to K63-linked diUb (PDB IDs: 3DVG and
3DVN), and humanized 4D5 Fab (PDB ID: 1FVE).Acknowledgements
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